Showing results (271-280 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|August 2, 2002
Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in functionBernard Bruguerolle, Nicolas SimonClinical Neuropharmacology|August 2, 2002
Weight and blood pressure change during clozapine treatmentScott P Baymiller, Patricia Ball, Robert P McMahon, et al.Clinical Neuropharmacology|August 2, 2002
Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's diseaseMarco Onofrj, Astrid Thomas, Anna Lisa Luciano, et al.Clinical Neuropharmacology|February 5, 2003
Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementiaRafael Stryjer, Rael D Strous, Faina Bar, et al.Clinical Neuropharmacology|January 22, 2002
Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathyC Wikell, F C Kugelberg, S Hjorth, et al.Clinical Neuropharmacology|January 22, 2002
Hypothermic action of exogenously administered melatonin is dose-dependent in humansK Satoh, K MishimaClinical Neuropharmacology|June 8, 2001
The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's diseaseH Heikkinen, J G Nutt, P A LeWitt, et al.Clinical Neuropharmacology|April 3, 2003
Mirtazapine-induced serotonin syndromeEroboghene E Ubogu, Bashar KatirjiClinical Neuropharmacology|April 3, 2003
High-dose olanzapine for treatment-refractory schizophreniaVladimir LernerClinical Neuropharmacology|April 3, 2003
Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's typeJoseph Bergman, Izidor Brettholz, Michael Shneidman, et al.Pageof 236